https://www.npr.org/sections/goats-and-soda/2024/07/03/g-s1-7988/hiv-prevention-drug-clinical-trial
Press release:
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention – First Phase 3 HIV Prevention Trial Ever to Show Zero...
